Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: GyroStim for Post Concussion Syndrome [NA]

View source ↗

Summary

GyroStim is being studied in a clinical trial for post-concussion syndrome. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GyroStim

Snippet

Sponsor: Neuroscience Group | Conditions: Post Concussion Syndrome | NA | Status: RECRUITING